C42H53NO15
Neat
811.88
-20°C
Room Temperature
aclarubicin; Aclacinomycin A; 57576-44-0; Aclarubicine; Aclarubicinum; aclarubicina; NSC-208734; MA 144-A1; 74KXF8I502; CHEBI:74619; NSC 208734; methyl (1R, 2R, 4S)-4-[(2R, 4S, 5S, 6S)-4-(dimethylamino)-5-[(2S, 4S, 5S, 6S)-4-hydroxy-6-methyl-5-[(2R, 6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2, 5, 7-trihydroxy-6, 11-dioxo-3, 4-dihydro-1H-tetracene-1-carboxylate; NSC208734; 1-Naphthacenecarboxylic acid, (2-ethyl-1, 2, 3, 4, 6, 11-hexahydro-2, 5, 7-trihydroxy-6, 11-dioxo-4-((2, 3, 6-trideoxy-4-O-(2, 6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-Lyxo-hexopyranosyl)oxy)-, methyl ester, (1R-(1alpha, 2beta, 4beta))-; Antibiotic MA144-A1; Aclacinomycin-A; NSC240619; methyl (1R, 2R, 4S)-4-((2R, 4S, 5S, 6S)-4-(dimethylamino)-5-((2S, 4S, 5S, 6S)-4-hydroxy-6-methyl-5-((2R, 6S)-6-methyl-5-oxooxan-2-yl)oxyoxan-2-yl)oxy-6-methyloxan-2-yl)oxy-2-ethyl-2, 5, 7-trihydroxy-6, 11-dioxo-3 and 4-dihydro-1H-tetracene-1-carboxylate; ACM-A; RefChem:915045
methyl (1R, 2R, 4S)-4-[(2R, 4S, 5S, 6S)-4-(dimethylamino)-5-[(2S, 4S, 5S, 6S)-4-hydroxy-6-methyl-5-[(2R, 6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2, 5, 7-trihydroxy-6, 11-dioxo-3 and 4-dihydro-1H-tetracene-1-carboxylate
InChI=1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1